Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
04/09/2003 | EP1299108A1 A parasiticidal formulation and a method of making this formulation |
04/09/2003 | EP1299107A2 Highly concentrated stable meloxicam solutions |
04/09/2003 | EP1299104A1 Tamper-resistant oral opioid agonist formulations |
04/09/2003 | EP1299095A1 Clear aqueous anaesthetic composition |
04/09/2003 | EP1299091A2 Matrix controlled transdermal system for stabile derivatives of ace inhibitors |
04/09/2003 | EP1299090A1 Oral pharmaceutical composition with controlled release and prolonged absorption |
04/09/2003 | EP1299089A2 Drug delivery system for poorly water soluble drugs |
04/09/2003 | EP1299088A1 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient |
04/09/2003 | EP1299087A1 Microspheres and adjuvants for dna vaccine delivery |
04/09/2003 | EP1299086A1 Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
04/09/2003 | EP1299085A2 Improved liposomal camptothecins and uses thereof |
04/09/2003 | EP1299084A2 Liposomal antineoplastic drugs and uses thereof |
04/09/2003 | EP1299083A1 Low molecular weight polymeric compositions |
04/09/2003 | EP1299068A1 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
04/09/2003 | EP1299048A1 Biodegradable vehicles and delivery systems of biologically active substances |
04/09/2003 | EP1299039A1 Use of a liquid medicament in surgical high pressure liquid jet devices |
04/09/2003 | EP1299005A1 Confectionery product containing active ingredients |
04/09/2003 | EP1298994A2 Method for opening the blood-brain barrier |
04/09/2003 | EP1200071B1 Low-dose tablets and preparation method |
04/09/2003 | EP1149090B1 Novel crystalline form of the potassium salt of (s)-omeprazole |
04/09/2003 | EP1140117B1 Aciclovir compositions containing dimethicone |
04/09/2003 | EP1061987A4 Drug delivery system |
04/09/2003 | EP1035837B1 Lipid compositions and their use |
04/09/2003 | EP1003568B1 Hemostatic tissue sealants |
04/09/2003 | EP1003477B1 Therapeutical system for transdermal delivery of levonorgestrel |
04/09/2003 | EP0994701B1 Block copolymer |
04/09/2003 | EP0948320B1 PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF THE HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN |
04/09/2003 | EP0938302B1 Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
04/09/2003 | EP0859597B1 Sustained release delivery system and long acting narcotic analgesics and antagonists |
04/09/2003 | EP0827396B1 Production scale method of forming microparticles |
04/09/2003 | EP0806940B1 Aerosol drug formulations |
04/09/2003 | EP0806894B1 Micellar nanoparticles |
04/09/2003 | EP0723455B1 Method of inhibiting phagocytosis |
04/09/2003 | CN1409720A Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
04/09/2003 | CN1409682A Injection-moulded water soluble container |
04/09/2003 | CN1409640A Polypeptide composition with improved stability |
04/09/2003 | CN1409638A Colistin sulfate granules |
04/09/2003 | CN1409636A Use of honey in medical dressings |
04/09/2003 | CN1409635A Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
04/09/2003 | CN1409631A New formulation |
04/09/2003 | CN1409630A Sustainable-release formulations for treating CNS-mediated disorders |
04/09/2003 | CN1409628A Adhesive preparations |
04/09/2003 | CN1409627A Novel apparatus and process for preparing crystalline particles |
04/09/2003 | CN1409605A Method for increasing pet activity |
04/09/2003 | CN1408427A Reduced type glutathione lozenge |
04/09/2003 | CN1408422A Chinese herbal medicine for curing periodontitis and gingivitis |
04/09/2003 | CN1408416A Chinese medicine sichuan chinaberry plaster for relieving pain and its preparing method |
04/09/2003 | CN1408415A Sichuan Chinaberry ointment and its preparing method |
04/09/2003 | CN1408410A External use plaster for curing cervical spondylopathy |
04/09/2003 | CN1408395A Paste for curing burn and scald and its preparing method |
04/09/2003 | CN1408392A Recipe of breviscapine drop pills and preparing method |
04/09/2003 | CN1408391A Paste for curing posriasis and its preparing method |
04/09/2003 | CN1408389A Traditional Chinese medicine for curing arrhythmia and its preparation |
04/09/2003 | CN1408388A Method for preparing nano American ginseng suspension |
04/09/2003 | CN1408381A Bear gall, liver protecting oral liquor and its producing method |
04/09/2003 | CN1408379A Notoginseng and pangolin scales tinea curing pill |
04/09/2003 | CN1408358A Recipe component of zinc gluconate colloid nose spray |
04/09/2003 | CN1408356A Composition of mifepristone semi-solid skeleton preparation |
04/09/2003 | CN1408351A Slow-release urea and its preparing method |
04/09/2003 | CN1408346A Elemene aerosol and its preparing method |
04/09/2003 | CN1408345A B-elemene aerosol and its preparing method |
04/09/2003 | CN1408344A Processing method for bighead atractylodes rhizome |
04/09/2003 | CN1408343A Nano material medicine or food |
04/09/2003 | CN1408342A Physical stable spraying gel composition |
04/09/2003 | CN1408339A Skin external preparation |
04/09/2003 | CN1408336A Complex room container preparation |
04/09/2003 | CN1104908C Improved vision through photodynamic therapy of eye |
04/09/2003 | CN1104905C Novel powder compositions |
04/09/2003 | CN1104901C Medicinal preparation containing lipophilicity inert gas |
04/09/2003 | CN1104899C Injectable quinolone formulations |
04/09/2003 | CN1104893C Percutaneous tulobuterol preparation and process for producing same |
04/09/2003 | CN1104891C Controlled release preparation |
04/09/2003 | CN1104890C Transparent ultramicro oil water emulsion using fluid non-ion amphiphilic lipid as main component and its applications in cosmetics and skin medicine |
04/08/2003 | US6546284 Fluid retention assembly for an iontophoretic delivery device and associated method for preparing the same |
04/08/2003 | US6546281 Integrated apparatus for controlled heat aided dermal drug delivery |
04/08/2003 | US6546268 Glucose sensor |
04/08/2003 | US6545169 Anticancer, antiprotozoa agents |
04/08/2003 | US6545138 Nucleic acid complex |
04/08/2003 | US6545097 Biocompatible block copolymer comprising one or more elastomeric blocks and one or more thermoplastic blocks connected by a seed polymer |
04/08/2003 | US6545058 Contains terpenoid as active ingredient |
04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
04/08/2003 | US6545046 Method for enhanced delivery of oxybutynin and compositions thereof |
04/08/2003 | US6545036 Potassium channel blockers; neuroprotectants, glaucoma, n-benzoyl indole compounds with 3-acylureamethyl group |
04/08/2003 | US6545007 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines |
04/08/2003 | US6544958 Therapy of respiratory influenza virus infection using free and liposome-encapsulated ribonucleotides |
04/08/2003 | US6544740 Measuring protease; calibration; insertion of enbryos |
04/08/2003 | US6544646 Zero order release and temperature-controlled microcapsules and process for the preparation thereof |
04/08/2003 | US6544566 For prophylaxis and minimizing development of atherosclerosis |
04/08/2003 | US6544562 For therapy of acne vulgaris, white heads, black heads and comedones |
04/08/2003 | US6544561 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
04/08/2003 | US6544559 Such as 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9 -tetrahydro-2-methyl-4H-pyrido (1,2-a)pyrimidin-4-one for sustained-release via biodegradation; for treatment of mental illness |
04/08/2003 | US6544558 Granulates compacted together into a tablet form together with an extra-granular lubricant; especially amoxycillin plus clavulanic acid, and crosslinked polyvinylpyrrolidone or sodium starch glycolate intra-granular disintegrant |
04/08/2003 | US6544557 Effervescent tablet compositions |
04/08/2003 | US6544556 Prevents gastrointestinal side effects |
04/08/2003 | US6544555 Dosage forms; variations in rrelease profile |
04/08/2003 | US6544554 Time-release agents |
04/08/2003 | US6544553 For hormone therapy |
04/08/2003 | US6544552 Method of producing porous tablets with improved dissolution properties |
04/08/2003 | US6544551 Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis |
04/08/2003 | US6544549 Multilamellar coalescence vesicles (MLCV) containing biologically active compounds |